摘要
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed variants escaping neutralization antibody immunity established against the original virus. An understanding of broad-spectrum adaptive immunity, including CD8(+) T cell immunity to wide range of epitopes, could help translational efforts to improve coronavirus disease 2019 (COVID-19) prevention and therapy. However, there have been few direct studies in which such immunity exists in a population. Methods: We selected SARS-CoV-2-conserved structural peptides that are not prone to mutation as antigens for broad-spectrum CD8(+) T cell immunity. Peripheral blood mononuclear cells (PBMCs) from unexposed healthy donors were stimulated with these peptides in vitro and CD8(+) T cell-specific response was monitored. The conserved peptide-specific CD8(+) T cells were sorted for T cell receptor (TCR) repertoire sequencing. The presence of specific complementary determining region 3 (CDR3) clones was analyzed in a healthy cohort. Results: For each structural protein, including S, E, M, N, the conserved peptides could potentially provide the largest number of major histocompatibility complex-I (MHC-I) epitopes in the Oriental and Caucasian populations. For conserved peptides from spike (S), envelope (E), membrane (M), nucleocapsid (N) proteins, we found that there were no cross-reactive memory T cells in the unexposed individuals. Instead, their T cells contain naive TCR repertoire recognizing these conserved peptides. Using TCR sequencing and CDR3 clustering for the conserved peptides specific T cells, we found that the recovered patients had a higher proportion of TCR repertoire similar with that of specific CD8(+) T cells in unexposed individuals. Meanwhile, CDR3 clones of the above T cells were widely present in the healthy population. Conclusions: This study provides evidence of broad-spectrum SARS-CoV-2 specific CD8(+) TCR repertoire in unexposed healthy population, which is implicated in the development and implementation of broad-spectrum vaccines against COVID-19.
学科与关键词
- Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variantsHu, Chao; Shen, Meiying; Han, Xiaojian; Chen, Qian; Li, Luo; Chen, Siyin; Zhang, Jing; Gao, Fengxia; Wang, Wang; Wang, Yingming; Li, Tingting; Li, Shenglong; Huang, Jingjing; Wang, Jianwei; Zhu, Ju; Chen, Dan; Wu, Qingchen; Tao, Kun; Pang, Da*; Jin, Aishun*Genes & Diseases, 2022, 9(1): 216-229.被引 21
- Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individualsDelmonte, Ottavia M.*; Oguz, Cihan; Dobbs, Kerry; Myint-Hpu, Katherine; Palterer, Boaz; Abers, Michael S.; Draper, Deborah; Truong, Meng; Kaplan, Ian M.; Gittelman, Rachel M.; Zhang, Yu; Rosen, Lindsey B.; Snow, Andrew L.; Dalgard, Clifton L.; Burbelo, Peter D.; Imberti, Luisa; Sottini, Alessandra; Quiros-Roldan, Eugenia; Castelli, Francesco; Rossi, Camillo; Brugnoni, Duilio; Biondi, Andrea; Bettini, Laura Rachele; D'Angio, Mariella; Bonfanti, Paolo; Anderson, Megan, VJournal of Allergy and Clinical Immunology, 2024, 153(6): 1655-1667.被引 3
- Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteinsDeng, Jieping; Pan, Junping; Qiu, Minghui; Mao, Lipeng; Wang, Zhigang; Zhu, Guodong; Gao, Lijuan; Su, Jun; Hu, Yutian; Luo, Oscar Junhong; Chen, Guobing*; Wang, Pengcheng*Journal of Leukocyte Biology, 2021, 110(6): 1171-1180.被引 9
